Physician profile
Ethan Fruechte
NPI 1043313976
$3,812.68
in general payments reported to CMS, 2019-2025
7 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,593 · 2020: $1,533 · 2022: $149 · 2023: $42.53 · 2024: $235 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,000.00 | 2019-2020 | |
| Boston Scientific Corporation | $552.33 | 2019-2025 | Watchman Flx, General - Therapies |
| Medtronic, INC. | $189.99 | 2022-2025 | Plasmablade(Tm), Reveal Linq |
| Cardiva Medical, INC. | $20.71 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Siemens Medical Solutions USA, INC. | $17.81 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Actelion Pharmaceuticals US, INC. | $16.43 | 2023 | Opsumit, Uptravi |
| Abbott Laboratories | $15.41 | 2024 | Sensitherm Multi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Fruechte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.